We performed immunofluorescence staining for ADAM9 on a cohort of non-smokers, chronic smokers, GOLD stage 4 COPD (with unknown or undefined PH status), and COPD-PH individuals (Fig. 5A). Here, ADAM9 is linked to chronic obstructive pulmonary disease.